Chongqing Pharscin Pharmaceutical Co., Ltd. logo

Chongqing Pharscin Pharmaceutical Co., Ltd. (002907)

Market Closed
7 Aug, 06:57
XSHE XSHE
¥
13. 50
+0.5
+3.8462%
¥
6.81B Market Cap
- P/E Ratio
0.14% Div Yield
8.03M Volume
- Eps
¥ 13
Previous Close
Add Transaction
Day Range
12.9 13.55
Year Range
11.42 19.32
Want to track 002907 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

002907 closed Friday higher at ¥13.5, an increase of 3.8462% from Thursday's close, completing a monthly increase of 2.818% or ¥0.37. Over the past 12 months, 002907 stock lost -8.9069%.
002907 pays dividends to its shareholders, with the most recent payment made on Jun 04, 2026. The next estimated payment will be in In 3 months on Dec 04, 2026 for a total of ¥0.04.
The last earnings report, released on May 22, 2025, exceeded the consensus estimates by 0.0966%. On average, the company has surpassed earnings expectations by 0.0966%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on one exchange.

002907 Chart

People also search for

Dr Corp Ltd.
¥ 23.35
-2.4237%
Sunvim Group Co., Ltd.
¥ 11.72
-3.3003%
Tibet Gaozheng Explosive Co., Ltd.
¥ 58.61
-1.6281%
Innovative Medical Management Co., Ltd.
¥ 21.24
-3.1022%
Henan Liliang Diamond Co., Ltd.
¥ 59.21
-1.366%

Chongqing Pharscin Pharmaceutical Co., Ltd. (002907) FAQ

What is the stock price today?

The current price is ¥13.50.

On which exchange is it traded?

Chongqing Pharscin Pharmaceutical Co., Ltd. is listed on XSHE.

What is its stock symbol?

The ticker symbol is 002907.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.14%.

What is its market cap?

As of today, the market cap is 6.81B.

Has Chongqing Pharscin Pharmaceutical Co., Ltd. ever had a stock split?

No, there has never been a stock split.

Chongqing Pharscin Pharmaceutical Co., Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Ms. Xiaoying Liu CEO
XSHE Exchange
CNE100003308 ISIN
CN Country
1,384 Employees
4 Jun 2026 Last Dividend
- Last Split
- IPO Date

Overview

Founded in 1996 and based in Chongqing, China, Chongqing Pharscin Pharmaceutical Co., Ltd. is a versatile pharmaceutical company involved in the comprehensive processes of research and development, production, and sale of diverse drugs within the Chinese market. The company is committed to addressing various medical needs, particularly specializing in the realm of CNS (Central Nervous System), digestion, otolaryngology, oncology, cardiovascular, and cerebrovascular diseases. Through a commitment to innovation and quality, Chongqing Pharscin Pharmaceutical stands as a significant player in the pharmaceutical industry of China.

Products and Services

Chongqing Pharscin Pharmaceutical Co., Ltd. offers a wide range of pharmaceutical products and services, including:

  • Tablets: These are solid doses of medication, designed for oral intake. Tablets are a primary format for many of the company's therapeutic agents, targeted towards various diseases and conditions.
  • Powders: Medicinal powders supplied by the company serve as another versatile form of drug delivery, often used for their ease of digestion and quick absorption.
  • Granules: Similar to powders, granules are small, rough particles of medication. They are typically used for their ease of use, particularly in pediatric and geriatric patients.
  • Soft Capsules: These are gelatin-based capsules that contain liquid or semi-solid drugs. Soft capsules are known for enhancing the bioavailability of certain medications.
  • Powder Injections: These products are designed for reconstitution into a liquid form before injection, serving as a method for delivering drugs directly into the bloodstream for fast action.
  • Freeze-dried Powders: Utilized primarily in the preparation of injections, freeze-dried powders offer a stable and effective way of preserving active pharmaceutical ingredients.
  • Injections: Liquid medications intended for administration via intravenous, intramuscular, or subcutaneous routes, injections are a cornerstone of the company's offerings for immediate therapeutic effects.
  • Chemical Raw Materials: Chongqing Pharscin Pharmaceutical also supplies various chemical raw materials used in the formulation of drugs, underscoring its role in the broader pharmaceutical supply chain.
  • Small Volume Injections: These are injections in volumes of 100 milliliters or less, designed for targeted treatment and reduced systemic exposure.

By providing a broad spectrum of pharmaceutical products, Chongqing Pharscin Pharmaceutical aims to cater to diverse healthcare needs, focusing on the treatment of critical and common conditions.

Contact Information

Address: No. 89, Middle Section of Huangshan Avenue, Chongqing, China, 401120
Phone: 86 23 6762 2999